Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
12 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/13/2996584/0/en/HUTCHMED-to-Receive-Milestone-Payment-from-Takeda-following-1st-European-Reimbursement-for-FRUZAQLA-fruquintinib.html
11 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/12/2995863/0/en/HUTCHMED-Announces-Breakthrough-Therapy-Designation-in-China-for-ORPATHYS-and-TAGRISSO-Combination-in-Certain-Lung-Cancer-Patients-After-Disease-Progression-on-EGFR-Inhibitor-Thera.html
03 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/03/2990362/0/en/HUTCHMED-and-Innovent-Jointly-Announce-NMPA-Conditional-Approval-for-ELUNATE-Fruquintinib-in-Combination-with-TYVYT-Sintilimab-Injection-for-the-Treatment-of-Advanced-Endometrial-C.html
28 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/28/2988577/0/en/HUTCHMED-Announces-Continued-Inclusion-of-ORPATHYS-savolitinib-in-the-National-Reimbursement-Drug-List-in-China-at-Current-Terms.html
21 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/22/2985718/0/en/HUTCHMED-Announces-Launch-by-Takeda-of-FRUZAQLA-fruquintinib-in-Japan.html
20 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/20/2984195/0/en/HUTCHMED-Announces-Appointment-of-Independent-Non-executive-Director-and-Member-of-Board-Committee.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?